ES2000108A4 - Peptidos con un grupo ester sulfato. - Google Patents

Peptidos con un grupo ester sulfato.

Info

Publication number
ES2000108A4
ES2000108A4 ES86117612T ES86117612T ES2000108A4 ES 2000108 A4 ES2000108 A4 ES 2000108A4 ES 86117612 T ES86117612 T ES 86117612T ES 86117612 T ES86117612 T ES 86117612T ES 2000108 A4 ES2000108 A4 ES 2000108A4
Authority
ES
Spain
Prior art keywords
peptidos
sulfato
group ester
peptides
new peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES86117612T
Other languages
English (en)
Other versions
ES2000108T3 (es
Inventor
James Donald Rosamond
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Fisons Corp
Original Assignee
Astra AB
Fisons Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra AB, Fisons Corp filed Critical Astra AB
Publication of ES2000108A4 publication Critical patent/ES2000108A4/es
Application granted granted Critical
Publication of ES2000108T3 publication Critical patent/ES2000108T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/595—Gastrins; Cholecystokinins [CCK]
    • C07K14/5955—Gastrins; Cholecystokinins [CCK] at least 1 amino acid in D-form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Obesity (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

NUEVOS PEPTIDOS QUE TIENEN GRUPOS ESTERES DE SULFATOS Y CONTIENEN DE 6 A 9 AMINOACIDOS; POSEEN PROPIEDADES PARA INHIBIR LA ALIMENTACION Y SON CAPACES DE ESTIMULAR LA CONTRACCION DE LA VESICULA BILIAR. TAMBIEN SE PRESENTAN LOS METODOS PARA EL TRATAMIENTO Y PREVENCION DE LA OBESIDAD EN QUE SE PUEDEN UTILIZAR ESTOS PEPTIDOS NUEVOS U OTROS PEPTIDOS ESPECIFICADOS.
ES86117612T 1985-12-19 1986-12-17 Peptidos con un grupo ester sulfato. Expired - Lifetime ES2000108T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US81094885A 1985-12-19 1985-12-19
US93211986A 1986-11-18 1986-11-18

Publications (2)

Publication Number Publication Date
ES2000108A4 true ES2000108A4 (es) 1987-12-01
ES2000108T3 ES2000108T3 (es) 1994-12-16

Family

ID=27123406

Family Applications (1)

Application Number Title Priority Date Filing Date
ES86117612T Expired - Lifetime ES2000108T3 (es) 1985-12-19 1986-12-17 Peptidos con un grupo ester sulfato.

Country Status (12)

Country Link
EP (1) EP0226217B1 (es)
JP (1) JP2569316B2 (es)
AT (1) ATE100821T1 (es)
AU (1) AU596388B2 (es)
DE (2) DE3689585T2 (es)
DK (1) DK608186A (es)
ES (1) ES2000108T3 (es)
FI (1) FI86193C (es)
IE (1) IE62659B1 (es)
IL (1) IL80971A (es)
NO (1) NO865132L (es)
NZ (1) NZ218607A (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5086042A (en) * 1985-12-19 1992-02-04 Fisons Corporation Peptides with sulfate ester groups
US4808701A (en) * 1987-03-30 1989-02-28 Hoffmann-La Roche Inc. Cyclic peptides having appetite regulating activity
ZA878594B (en) * 1987-05-27 1989-07-26 Pennwalt Corp Peptides with sulfate ester groups
ZA883929B (en) * 1987-06-22 1990-02-28 Hoffmann La Roche Cholecystokinin analogs for controlling appetite
US5182263A (en) * 1988-04-25 1993-01-26 Hoffmann-La Roche Inc. Analogs of tyrosine sulfate or tyrosine phosphate containing peptides
JPH0219396A (ja) * 1988-07-06 1990-01-23 Shionogi & Co Ltd 新規ペプチドおよびそれを含有する脳機能改善剤
FR2634763B1 (fr) * 1988-08-01 1991-07-12 Inst Nat Sante Rech Med Amino-acides et peptides presentant un residu tyrosine modifiee, leur preparation et leur application comme medicaments
US5631230A (en) * 1989-09-21 1997-05-20 Arizona Technology Development Corporation Receptor selective analogues of cholecystokinin-8
US5502164A (en) * 1989-11-27 1996-03-26 Fisons Corporation Peptide compounds having therapeutic activity
ES2069272T3 (es) * 1989-11-27 1995-05-01 Fisons Corp Hexapeptidos con grupos esteres sulfato.
WO1992019253A1 (en) * 1991-04-24 1992-11-12 Warner-Lambert Company CCK ANALOGS CONTAINING α-SUBSTITUTED AMINO ACIDS
MX9207458A (es) * 1991-12-20 1993-11-01 Fisons Corp Compuestos de peptido que tienen actividad terapeutica.
JP2007506730A (ja) * 2003-09-24 2007-03-22 ベクタ・リミテッド ペンタガストリンを含む胃酸分泌刺激用経口組成物
CN103833593B (zh) * 2014-03-21 2016-08-17 四川什邡市三高生化实业有限公司 一种n-(9-芴甲氧羰基)-o-叔丁基-l-酪氨酸的制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4842633A (es) * 1971-09-30 1973-06-21
JPS5130069A (ja) * 1974-09-05 1976-03-13 Nogyo Kikaika Kenkyusho Kokumotsushuyobukuro
DD128973B1 (de) * 1976-11-29 1979-11-28 Hartmut Niedrich Verfahren zur herstellung von peptiden,die tyrosinsulfat enthalten
US4351829A (en) * 1980-09-26 1982-09-28 Farmitalia Carlo Erba Spa Use of polypeptides as analgesic drugs
JPS57146745A (en) * 1981-03-09 1982-09-10 Amano Pharmaceut Co Ltd Peptide amidosulfate ester derivative and its preparation
JPS6028992A (ja) * 1983-07-20 1985-02-14 Amano Pharmaceut Co Ltd ペプチド及びこれを含有する抗精神分裂病薬剤
DK489683A (da) * 1982-10-27 1984-04-28 Amano Pharma Co Ltd Fremgangsmaade til fremstilling af peptider
JPS5978151A (ja) * 1982-10-27 1984-05-04 Amano Pharmaceut Co Ltd 新規ペプチド及びこれを含有する抗精神分裂病薬剤
US4490364A (en) * 1983-05-20 1984-12-25 The Salk Institute For Biological Studies CCK Agonists II
JPS60100595A (ja) * 1983-11-04 1985-06-04 Amano Pharmaceut Co Ltd 新規ペプチド
JPS60194000A (ja) * 1984-03-14 1985-10-02 Amano Pharmaceut Co Ltd ペプチドアミドスルフエ−トエステル
EP0161468A3 (en) * 1984-05-07 1988-10-26 Pennwalt Corporation Process for the solid phase synthesis of peptides which contain sulfated tyrosine
JPS62126198A (ja) * 1985-11-26 1987-06-08 Amano Pharmaceut Co Ltd ペプチドアミドスルフエ−トエステル

Also Published As

Publication number Publication date
AU6671486A (en) 1987-06-25
EP0226217B1 (en) 1994-01-26
FI865163L (fi) 1987-06-20
JPS62228100A (ja) 1987-10-06
IE62659B1 (en) 1995-02-22
DK608186D0 (da) 1986-12-17
DE3689585T2 (de) 1994-07-07
FI86193B (fi) 1992-04-15
EP0226217A2 (en) 1987-06-24
FI865163A0 (fi) 1986-12-17
DE226217T1 (de) 1988-01-14
AU596388B2 (en) 1990-05-03
IL80971A (en) 1991-12-12
DE3689585D1 (de) 1994-03-10
NO865132D0 (no) 1986-12-17
NO865132L (no) 1987-06-22
NZ218607A (en) 1989-10-27
ES2000108T3 (es) 1994-12-16
IL80971A0 (en) 1987-03-31
IE863300L (en) 1987-06-19
ATE100821T1 (de) 1994-02-15
DK608186A (da) 1987-08-20
EP0226217A3 (en) 1989-05-24
JP2569316B2 (ja) 1997-01-08
FI86193C (fi) 1992-07-27

Similar Documents

Publication Publication Date Title
ES2000108A4 (es) Peptidos con un grupo ester sulfato.
DE3889536D1 (de) Behandlung von krebs mit somatostatin und mit analogen davon.
BR8503621A (pt) Envoltorio e retentor de suturas retangular alongado e envoltorio e retentor para uma pluralidade de suturas
DE69027865D1 (de) ZUSAMMENSETZUNGEN enthaltend omega Conotoxin Peptide Derivate und deren Verwendung ZUR BEHANDLUNG VON ISCHÄMIE-ARTIGEN NEURONALEN SCHÄDIGUNGEN
NZ227787A (en) Peptides and compositions having growth hormone regulatory effects
DE3583008D1 (de) Pharmazeutische zusammensetzungen von dihydrocodeine/ibuprofen und verfahren.
DE69434218D1 (de) Photodynamische behandlung von synovium
IT1232889B (it) Composizioni e procedimento per il trattamento ammorbidente di tessuti
ATE177757T1 (de) Verbesserte immunogene zusammensetzung gegen mensliches gastrin 17
ES2179319T3 (es) Acido linoleico conjugado para mantener o aumentar el contenido de minerales de los huesos.
DK0918516T3 (da) Fremgangsmåde til forebyggelse af skeletale problemer hos fjerkræ
ES2103854T3 (es) Peptidos con actividad organo protectiva, procedimiento para la preparacion de los mismos y su utilizacion en la terapia.
ATE210149T1 (de) Entzündungshemmende zusammensetzung und methode, in welchen des-tyr dynorphin und analoge benutzt werden
ES2005522A4 (es) Peptidos con grupos ester sulfato.
DE69420827D1 (de) Verfahren zur Herstellung von wässrigen Emulsionen zur Umhüllung von festen pharmazeutischen Zusammensetzungen
ES548052A0 (es) Procedimiento para preparar peptidos
HU0102043D0 (en) Pharmaceutical compounds which interact with an ca2+ channel alpha2delta subunit
ES2039578T3 (es) Procedimiento para producir mercapto-acilaminoacidos antihipertensivos.
IT1211635B (it) Metodo per aumentare il regime di crescita di animali e composizione in esso impiegata
DE69429521D1 (de) Zusammensetzung und verfahren zur stimulation der reproduzierenden leistung
ES517596A0 (es) Procedimiento para la preparacion de un peptido.
SE8500102D0 (sv) Forfarande for mikrofloraavlossning
BR9911388A (pt) Imunógeno de somatostatina sintético para promoção de crescimento em animais de fazenda
MX17601A (es) Composicion para el tratamiento de leishmaniasis yprocedimiento para su preparacion .
MX9707501A (es) Dominio intracelular de la proteina her-2/neu para la prevencion o tratamiento de malignidades.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 226217

Country of ref document: ES